NAS ClearPath used in APBI procedure

North American Scientific (NAS) of Chatsworth, CA, has announced that its ClearPath-HDR device has been used in a patient for the first time.

ClearPath-HDR is used in accelerated partial-breast irradiation (APBI) treatment plans, combining balloon brachytherapy with customized dose planning of a multicatheter brachytherapy procedure into one device.

The technology is designed to allow doctors to use a five-day APBI treatment plan, rather than six to eight weeks required for external beam treatment plans. ClearPath is implanted through a single incision and is intended to minimize radiation exposure of nearby healthy tissue.

By staff writers
September 28, 2007

Related Reading

NAS receives Nasdaq notice, September 25, 2007

NAS posts mixed results in Q3, September 21, 2007

NAS completes sale of Nomos unit, September 19, 2007

NAS signs deal to sell Nomos unit, September 12, 2007

NAS names Barring as COO, September 7, 2007

Copyright © 2007

Page 1 of 461
Next Page